Creative BioMart Provides MHC Solutions for Cell Therapy & Vaccine Development

Posted December 14, 2022 by caroline91

Creative BioMart now offers MHC solutions for cell therapy and vaccine development.
Creative BioMart, a biotechnology company that offers a wide range of solutions dedicated to
helping researchers and pharmaceutical companies discover and develop novel drugs in the
treatment of cancer, autoimmune diseases, etc., now offers MHC solutions for cell therapy and
vaccine development.

According to the official speaker from Creative BioMart, based on MHC-like complexes that can
directly identify and isolate antigen-specific T cells or screen and identify MHC-like antigens
that can be used for vaccine development, the company can provide two therapeutic
development services: cell therapy and vaccine development.

Service Range
MHC Neoepitopes Discovery
For the development of therapeutic cancer vaccines and T-cell therapies, as well as an evergrowing neoepitope dataset for client program development, immunogenic neoepitopes are
selected, characterized, and monitored in studies.

Cancer Vaccine Development Based on pMHC
Cancer vaccines to enhance the immune response, target tumor-specific mutations not present
in normal tissues, and eradicate tumors.

Vaccine Development Based on VLPs with MHC Complex
To demonstrate and deliver specific tumor-associated MHC complex antigens and create more
scalable and safe cancer vaccines, VLPs are used as particle scaffolds.

Cell Therapy Discovery Based on TCR-pMHC
Platform for quickly and efficiently detecting TCR-pMHC interactions.

Service Advantages
MHC immunopeptidomic analysis technology for the discovery of tumor-specific neoantigens
Diversified solutions for various cancer types including liver, cervical, and breast caner

More sensitive, stable and quantitative workflow

Comprehensive in-house tools like MHC binding experiments, MHC binding prediction tools, Tcell immunogenicity prediction tools, etc.

“We provide comprehensive and extensive research for mass immunotherapy development in
the MHC analysis field. And we believe that our cutting-edge technology and diverse product
offering can provide a valuable resource and new insights into personalized immunotherapy for
cancer.” Commented Linna, the chief marketing staff at Creative BioMart.

To know more detailed information about the MHC Solutions for Cell Therapy & Vaccine
Development provided by Creative BioMart, please visit
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Creative BioMart
Country United States
Categories Biotech
Tags mhc solutions , cell therapy vaccine development
Last Updated December 14, 2022